Journal
CELL RESEARCH
Volume 29, Issue 11, Pages 875-876Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41422-019-0245-5
Keywords
-
Categories
Ask authors/readers for more resources
Cancer stem cells (CSCs) achieved prominence as a concept to explain the inexorable growth of cancers, but the paucity of robust CSC markers for solid tumors has seen the field wane in recent years. Wang et al. now report that a cell surface protein PROCR (Protein C Receptor) enriches for CSCs in about half of triple negative breast cancers and show that inhibition of receptor function by a nanobody profoundly decreases tumor growth, thus highlighting PROCR as a potential therapeutic target.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available